U.S. Markets close in 1 hr 20 mins

Research Report Identifies PDL BioPharma, TEGNA, Patterson Companies, Boardwalk Pipeline Partners, Exact Sciences, and Berkshire Hathaway with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PDL BioPharma, Inc. (PDLI), TEGNA Inc. (TGNA), Patterson Companies, Inc. (PDCO), Boardwalk Pipeline Partners L.P. (BWP), Exact Sciences Corporation (EXAS), and Berkshire Hathaway Inc. (BRK-B), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PDLI DOWNLOAD: http://Fundamental-Markets.com/register/?so=PDLI
TGNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGNA
PDCO DOWNLOAD: http://Fundamental-Markets.com/register/?so=PDCO
BWP DOWNLOAD: http://Fundamental-Markets.com/register/?so=BWP
EXAS DOWNLOAD: http://Fundamental-Markets.com/register/?so=EXAS
BRK-B DOWNLOAD: http://Fundamental-Markets.com/register/?so=BRK-B

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine PDL BioPharma, Inc. (PDLI), TEGNA Inc. (TGNA), Patterson Companies, Inc. (PDCO), Boardwalk Pipeline Partners L.P. (BWP), Exact Sciences Corporation (EXAS), and Berkshire Hathaway Inc. (BRK-B) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

PDL BIOPHARMA, INC. (PDLI) REPORT OVERVIEW

PDL BioPharma's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, PDL BioPharma reported revenue of $38.52MM vs $45.44MM (down 15.23%) and basic earnings per share $0.01 vs $0.04 (down 75.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, PDL BioPharma reported revenue of $320.06MM vs $244.30MM (up 31.01%) and basic earnings per share $0.71 vs $0.39 (up 82.05%). PDL BioPharma is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.26. The estimated EPS forecast for the next fiscal year is $0.23 and is expected to report on March 14th, 2019.

To read the full PDL BioPharma, Inc. (PDLI) report, download it here: http://Fundamental-Markets.com/register/?so=PDLI

-----------------------------------------

TEGNA INC. (TGNA) REPORT OVERVIEW

TEGNA's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, TEGNA reported revenue of $502.09MM vs $459.07MM (up 9.37%) and basic earnings per share $0.26 vs $0.27 (down 3.70%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, TEGNA reported revenue of $1,903.03MM vs $2,004.09MM (down 5.04%) and basic earnings per share $1.27 vs $2.02 (down 37.13%). TEGNA is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next fiscal year is $1.51 and is expected to report on March 7th, 2019.

To read the full TEGNA Inc. (TGNA) report, download it here: http://Fundamental-Markets.com/register/?so=TGNA

-----------------------------------------

PATTERSON COMPANIES, INC. (PDCO) REPORT OVERVIEW

Patterson Companies' Recent Financial Performance

For the three months ended January 31st, 2018 vs January 31st, 2017, Patterson Companies reported revenue of $1,375.22MM vs $1,397.42MM (down 1.59%) and basic earnings per share $1.18 vs $0.26 (up 353.85%). For the twelve months ended April 30th, 2017 vs April 30th, 2016, Patterson Companies reported revenue of $5,593.13MM vs $5,386.70MM (up 3.83%) and basic earnings per share $1.80 vs $1.93 (down 6.74%). Patterson Companies is expected to report earnings on August 23rd, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.44. The estimated EPS forecast for the next fiscal year is $1.86 and is expected to report on June 20th, 2019.

To read the full Patterson Companies, Inc. (PDCO) report, download it here: http://Fundamental-Markets.com/register/?so=PDCO

-----------------------------------------

BOARDWALK PIPELINE PARTNERS L.P. (BWP) REPORT OVERVIEW

Boardwalk Pipeline Partners' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Boardwalk Pipeline Partners reported revenue of $335.40MM vs $367.00MM (down 8.61%) and basic earnings per share $0.38 vs $0.47 (down 19.15%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Boardwalk Pipeline Partners reported revenue of $1,322.60MM vs $1,307.20MM (up 1.18%) and basic earnings per share $1.16 vs $1.18 (down 1.69%). Boardwalk Pipeline Partners is expected to report earnings on July 30th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.28. The estimated EPS forecast for the next fiscal year is $1.01 and is expected to report on February 11th, 2019.

To read the full Boardwalk Pipeline Partners L.P. (BWP) report, download it here: http://Fundamental-Markets.com/register/?so=BWP

-----------------------------------------

EXACT SCIENCES CORPORATION (EXAS) REPORT OVERVIEW

Exact Sciences' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Exact Sciences reported revenue of $90.30MM vs $48.36MM (up 86.70%) and basic earnings per share -$0.33 vs -$0.32. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Exact Sciences reported revenue of $265.99MM vs $99.38MM (up 167.66%) and basic earnings per share -$0.99 vs -$1.63. Exact Sciences is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.27. The estimated EPS forecast for the next fiscal year is -$0.35 and is expected to report on February 28th, 2019.

To read the full Exact Sciences Corporation (EXAS) report, download it here: http://Fundamental-Markets.com/register/?so=EXAS

-----------------------------------------

BERKSHIRE HATHAWAY INC. (BRK-B) REPORT OVERVIEW

Berkshire Hathaway's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Berkshire Hathaway reported revenue of $58,473.00MM vs $64,370.00MM (down 9.16%) and basic earnings per share -$0.46 vs $1.64. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Berkshire Hathaway reported revenue of $242,137.00MM vs $223,604.00MM (up 8.29%) and basic earnings per share $18.20 vs $9.76 (up 86.48%). Berkshire Hathaway is expected to report earnings on August 3rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.67. The estimated EPS forecast for the next fiscal year is $9.52 and is expected to report on February 22nd, 2019.

To read the full Berkshire Hathaway Inc. (BRK-B) report, download it here: http://Fundamental-Markets.com/register/?so=BRK-B

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.